Jamie Heywood

The International Consortium for Health Outcomes Measurement (ICHOM) is a non-profit organisation founded by three esteemed institutions with the purpose to transform health care systems worldwide by measuring and reporting patient outcomes in a standardised way. We believe outcomes are the ultimate measure of success in health care. When seeking treatment, patients want to know what their life will be like after treatment: will I return to work, will I be able to take care of myself, and will my symptoms improve? Helping patients answer these questions is why we formed ICHOM. ICHOM organises global teams of physician leaders, outcomes researchers and patient advocates to define Patient-Centered Outcomes Measures of outcomes per medical condition, and then drives adoption to enable health care providers globally to compare, learn, and improve. We debuted our first Patient-Centered Outcomes Measures for cataracts, coronary artery disease, localized prostate cancer, and low back pain - in November 2013. We have now completed over 40 Patient-Centered Outcomes Measures of the world's most burdensome conditions. ICHOM's Values. We are: Collaborative: We build trusted, collaborative relationships worldwide. Focused: We focus on the things that have the greatest impact. Transparent: We will always be independent, honest, and transparent. Quality: Our people have a deep understanding, are patient-centric, and maintain the highest quality in all they do. Ambitious: Our ambition is to transform healthcare and change patient lives. We are an international team of diverse professionals striving to make a positive change in healthcare. We welcome people from different backgrounds across the world as what we value most is expertise, experience and enthusiasm to drive the mission forward. ICHOM is a truly global organisation. Visit us online and follow us on Instagram: @ichom_org , Twitter: @ICHOM_ORG and Facebook: International Consortium for Health Outcomes Measurement

Everyone.org is a social enterprise that helps patients with diseases such as Cancer, MS, ALS and Parkinson's disease access the very latest approved medicines that are not available in their own country. We are a registered, independent health platform, that manages the access, sourcing, and delivery of the medicine to patients across the world - with 52 countries so far delivered to. We put people first - and stimulate new dialogues between physicians and patients. To date we've delivered over 5,500 overseas-approved medicines to patients, in as little as 8 days from order to receipt. Our goal is to create a world where there is an open-door to health and wellbeing for all.

AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.

The ALS Therapy Development Institute (ALS TDI) and its researchers discover and develop potential treatments for ALS. It is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Led by drug development experts and people living with ALS, ALS TDI understands the urgent need to slow and stop this disease. Based in the Greater Boston Area, ALS TDI has over 30 full-time, industry trained, drug development experts on staff. ALS TDI is internationally recognized as a leader in preclinical and translational ALS research, and partners with pharmaceutical companies and biotechs around the world. Rated a four-star nonprofit on Charity Navigator, ALS TDI spends 87 cents of every dollar raised on research to find an effective treatment and cure. Learn more at www.als.net.

“In physical science the first essential step in the direction of learning any subject is to find principles of numerical reckoning and practicable methods for measuring some quality connected with it. I often say that when you can measure what you are speaking about, and express it in numbers, you know something about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a meagre and unsatisfactory kind; it may be the beginning of knowledge, but you have scarcely in your thoughts advanced to the state of Science, whatever the matter may be.” — Lord Kelvin

https://onlinecareer360.com/

The International Consortium for Health Outcomes Measurement (ICHOM) is a non-profit organisation founded by three esteemed institutions with the purpose to transform health care systems worldwide by measuring and reporting patient outcomes in a standardised way. We believe outcomes are the ultimate measure of success in health care. When seeking treatment, patients want to know what their life will be like after treatment: will I return to work, will I be able to take care of myself, and will my symptoms improve? Helping patients answer these questions is why we formed ICHOM. ICHOM organises global teams of physician leaders, outcomes researchers and patient advocates to define Patient-Centered Outcomes Measures of outcomes per medical condition, and then drives adoption to enable health care providers globally to compare, learn, and improve. We debuted our first Patient-Centered Outcomes Measures for cataracts, coronary artery disease, localized prostate cancer, and low back pain - in November 2013. We have now completed over 40 Patient-Centered Outcomes Measures of the world's most burdensome conditions. ICHOM's Values. We are: Collaborative: We build trusted, collaborative relationships worldwide. Focused: We focus on the things that have the greatest impact. Transparent: We will always be independent, honest, and transparent. Quality: Our people have a deep understanding, are patient-centric, and maintain the highest quality in all they do. Ambitious: Our ambition is to transform healthcare and change patient lives. We are an international team of diverse professionals striving to make a positive change in healthcare. We welcome people from different backgrounds across the world as what we value most is expertise, experience and enthusiasm to drive the mission forward. ICHOM is a truly global organisation. Visit us online and follow us on Instagram: @ichom_org , Twitter: @ICHOM_ORG and Facebook: International Consortium for Health Outcomes Measurement

Beyond targets. We accelerate the discovery and development of optimal candidate compounds for pre-clinical and clinical testing. Our proprietary GeneScapeTM platform enables applied modular biology and the identification of the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.

Everyone.org is a social enterprise that helps patients with diseases such as Cancer, MS, ALS and Parkinson's disease access the very latest approved medicines that are not available in their own country. We are a registered, independent health platform, that manages the access, sourcing, and delivery of the medicine to patients across the world - with 52 countries so far delivered to. We put people first - and stimulate new dialogues between physicians and patients. To date we've delivered over 5,500 overseas-approved medicines to patients, in as little as 8 days from order to receipt. Our goal is to create a world where there is an open-door to health and wellbeing for all.